Beviprex^TM

Indication:
For the maintenance treatment of patients with Chronic Obstructive Pulmonary Disease (COPD), including chronic bronchitis and/or emphysema.

Dosage & Administration:
Adults: Should be administered 2 puffs twice daily, in the morning and in the evening.

Preparation:
BeviprexTM HFA Inhaler: Each puff delivers Glycopyrronium Bromide 9 mcg and Formoterol Fumarate 4.8 mcg. Each Inhaler delivers 120 puffs.